Abdul Razaq Almadani

Higher Committee for Medical Liability Chairman [linebreak] UAE

Dr. Abdulrazzaq Ali Al Madani is consultant physician and endocrinologist at Al Borj Medical Centre in Dubai since 1998

After graduating in Medicine from Ain Shams University, Cairo, Dr. Madani pursued his Postgraduate training in Internal Medicine and Endocrinology from Munich, Germany and obtained his Fachartz in both specialties. The Royal College of Physicians awarded Dr. Madani Honorary Fellowship from their Colleges in Edinburg and Glasgow.

Dr. Madani joined Dubai Health Authority in 1980 and since 1993 holds the post of Consultant in Medicine and Endocrinology. In 2000 he became the head of the medical department, in 2002 became the Chief Executive Officer (CEO) of Dubai Hospital-DHA till 2014. He is also consultant physician and endocrinologist at Al Borj Medical Centre in Dubai since 1998. Currently he is a member of the advisory board for the minister of health and chairman of the higher medical liability committee in UAE.

Dr. Madani was awarded the Sheikh Rashid Award for Scientific Achievement in 1988 and was honored with the Dubai Government Excellence Award (DGEP) in 2002 under the Category – Distinguished Employee.

Dr. Madani is the Honorary President of the Emirates Diabetes Society and the Chairman of the Gulf Group for Study of Diabetes.

Dr. Madani headed the group who prepared the “UAE National Diabetes Guidelines”.

He has acted as the chairman of the local organizing committee of IDF Congress in Dubai 2011 and the chairman of the local organizing committee of IDF Congress in Abu Dhabi 2017.

His publications in Clinical Diabetes include “Recommendations for Management of Diabetes During Ramadan”, “Diabetes Care, Algorithm for Management of Type 2 in the Middle East”, “Diabetes Education in the Arab World, A Call for Action”, Driving and diabetes mellitus in the Gulf Cooperation Council countries: Call for action. and “UAE National Diabetes Guidelines 2008 and 2011”, Diabetes and Ramadan: Practical Guidelines (IDF/DAR), and IDF Guidelines, Oral health for people with diabetes.